This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Recombinant vaccines in 2022: a perspective from the cell factory
Microbial Cell Factories Open Access 05 October 2022
-
Plant-based solutions for veterinary immunotherapeutics and prophylactics
Veterinary Research Open Access 31 December 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
News In Brief. Nat Biotechnol 24, 233–234 (2006). https://doi.org/10.1038/nbt0306-233
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0306-233
This article is cited by
-
Plant-made pharmaceuticals: exploring studies for the production of recombinant protein in plants and assessing challenges ahead
Plant Biotechnology Reports (2023)
-
Recombinant vaccines in 2022: a perspective from the cell factory
Microbial Cell Factories (2022)
-
Seed-Based System for Cost-Effective Production of Vaccine Against Chronic Respiratory Disease in Chickens
Molecular Biotechnology (2022)
-
Current state-of-the-art in the use of plants for the production of recombinant vaccines against infectious bursal disease virus
Applied Microbiology and Biotechnology (2020)
-
Plant-based solutions for veterinary immunotherapeutics and prophylactics
Veterinary Research (2014)